Coccidioidomycosis

Infectious Disease Clinics of North America

Volumn 20, Issue 3, 2006, Pages 621-643

  Anstead, Gregory M ^a,b   Graybill, John R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; DEXAMETHASONE; ECHINOCANDIN; FLUCONAZOLE; GAMMA INTERFERON; ITRACONAZOLE; KETOCONAZOLE; METHYLPREDNISOLONE; POSACONAZOLE; VORICONAZOLE;

AFRICAN AMERICAN; ARACHNOIDITIS; BIOLOGICAL WARFARE; COCCIDIOIDOMYCOSIS; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; DRUG WITHDRAWAL; ENDEMIC DISEASE; FILIPINO; GASTROINTESTINAL SYMPTOM; GEOGRAPHIC DISTRIBUTION; HORMONE DEFICIENCY; HOST SUSCEPTIBILITY; HUMAN; HYDROCORTISONE RELEASE; INFARCTION; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MEXICO; RELAPSE; REVIEW; RISK FACTOR; SOIL MICROFLORA; SPECIES IDENTIFICATION; SYMPTOMATOLOGY; TERATOGENICITY; TESTOSTERONE RELEASE; UNITED STATES; VASCULITIS;

ANTIFUNGAL AGENTS; COCCIDIOIDOMYCOSIS; HUMANS;

EID: 33748553359     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2006.06.005     Document Type: Review

References (113)

1. Bailek R., Kern J., Herrmann T., et al. PCR assays for the identification of Coccidioides posadasii based on the nucleotide sequence of antigen 2/proline-rich antigen. J Clin Microbiol 42 (2004) 778-783
2. Stevens D.A. Current concepts: coccidioidomycosis. N Engl J Med 332 (1995) 1077-1082
3. Crum N.F., Lederman E.R., Stafford C.M., et al. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and emerging controversies. Medicine (Baltimore) 83 (2004) 149-175
4. Park B.J., Sigel K., Vaz V., et al. An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001. J Infect Dis 191 (2005) 1981-1987
5. Galgiani J.N., Ampel N.M., Blair J.E., et al. Coccidioidomycosis. Clin Infect Dis 41 (2005) 1217-1223
6. Kolivras K.N., and Comrie A.C. Modeling valley fever (coccidioidomycosis) incidence on the basis of climatic conditions. Int J Biometeorol 47 (2003) 87-101
7. Galgiani J.N. Coccidioidomycosis: a regional disease of national importance. Rethinking approaches to control. Ann Intern Med 130 (1999) 293-300
8. Petersen L.R., Marshall S.L., Barton-Dickson C., et al. Coccidioidomycosis among workers at an archaeological site, northeastern Utah. Emerg Infect Dis 10 (2004) 637-642
9. Ampel N.M. Coccidioidomycosis in persons infected with HIV type 1. Clin Infect Dis 41 (2005) 1174-1178
10. Wright P.W., Pappagiannis D., Wilson M., et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 37 (2003) 1265-1269
11. Bergstrom L., Yocum D.E., Ampel N.M., et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum 50 (2004) 1959-1966
12. Peterson C.M., Schuppert K., Kelly P.C., et al. Coccidioidomycosis and pregnancy. Obstet Gynecol Surv 48 (1993) 149-156
13. Blair J.E., Smilack J.D., and Caples S.M. Coccidioidomycosis in patients with hematologic malignancies. Arch Intern Med 165 (2005) 113-117
14. Deresinski S.C., Pappagianis D., and Stevens D. Association of ABO blood group and outcome of coccidioidal infections. Sabouraudia 17 (1979) 261-264
15. Flynn N., Hoeprich P., Kawachi M., et al. An unusual outbreak of windborne coccidioidomycosis. N Engl J Med 301 (1979) 358-361
16. Schneider E., Hajjeh R., Spiegel R., et al. A coccidioidomycosis outbreak following Northridge, Calif, earthquake. JAMA 277 (1997) 904-908
17. Williams P.L., Sable D.L., Mendez P., et al. Symptomatic coccidioidomycosis following a severe natural dust storm. An outbreak at the Naval Air Station, Lemoore, Calif. Chest 76 (1979) 566-570
18. Pappagianis D. Marked increases in cases of coccidioidomycosis in California: 1991, 1992, and 1993. Clin Infect Dis 19 Suppl 1 (1994) S14-S18
19. Ampel N.M. Coccidioidomycosis. In: Dismukes W., Pappas P., and Sobel J. (Eds). Clinical mycology (2003), Oxford University Press, New York 311-327
20. Galgiani J. Coccidioides species. In: Mandel G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases. 6th edition (2005), Churchill Livingstone, New York 3040-3050
21. Pappagianis D. Coccidioidomycosis. In: Merz W., and Hay R.J. (Eds). Topley and Wilson's medical mycology. 10th edition (2005), ASM Press, Washington (DC) 502-518
22. Pappagianis D., and Zimmer B.L. Serology of coccidioidomycosis. Clin Microbiol Rev 3 (1990) 247-268
23. Pappagianis D. Serologic studies in coccidioidomycosis. Semin Respir Infect 16 (2001) 242-250
24. Smith C.E., Saito M.T., and Simons S.A. Pattern of 39,500 serologic tests in coccidioidomycosis. JAMA 160 (1956) 546-552
25. Graybill J.R., Stevens D.A., Galgiani J.N., et al., for the NIAID Mycoses Study Group. Itraconazole treatment of coccidioidomycosis. Am J Med 89 (1990) 292-300
26. Kelly P.C. Coccidioidal meningitis. In: Stevens D.A. (Ed). Coccidioidomycosis: a text (1980), Plenum, New York 163-193
27. Pappagianis D., Saito M., and Van Hoosear K.H. Antibody in cerebrospinal fluid in non-meningitis coccidioidomycosis. Sabouraudia 10 (1972) 173-179
28. Kelly P.C., Sievers M.L., Thompson R., et al. Coccidioidal meningitis: results of treatment in 22 patients. In: Ajello L. (Ed). Coccidioidomycosis, current clinical and diagnostic studies (1977), Symposia Specialists, Miami (FL) 239-251
29. Galgiani J.N., Catanzaro A., Cloud G.A., et al. Fluconazole therapy for coccidioidal meningitis. Ann Intern Med 119 (1993) 28-35
30. Kaufman L., Sekhon A.S., Molidina N., et al. Comparative evaluation of commercial premier EIA and microimmunodiffusion and complement fixation tests for Coccidioides immitis antibodies. J Clin Microbiol 33 (1995) 618-619
31. Martins T.B., Jaskowski T.D., Mouritsen C.L., et al. Comparison of commercially available enzyme immunoassay with traditional serological tests for detection of antibodies to Coccidioides immitis. J Clin Microbiol 33 (1995) 940-943
32. Wheat L.J., Wheat H., Connolly P., et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 24 (1997) 1169-1171
33. Bialek R., Johnson S.M., and Pappagianis K.A. Amplification of coccidioidal DNA in clinical specimens by PCR. J Clin Microbiol 43 (2005) 1492-1493
34. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium forming filamentous fungi: proposed standard. NCCLS document M38-P (1998), National Committee for Clinical Laboratory Standards, Wayne (PA)
35. Gonzalez G.M., Tijerna R., Najvar L.K., et al. Correlation between antifungal susceptibilities of Coccidioides immitis (CI) in vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother 45 (2001) 1854-1859
36. Galgiani J.N., Catanzaro A., Cloud G.A., et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis-a randomized, double-blind trial. Ann Intern Med 133 (2000) 676-686
37. Johnson R.H., and Einstein H.E. Coccidioidal meningitis. Clin Infect Dis 42 (2006) 103-106
38. Drutz D. Coccidioidal pneumonia. In: Pennington J. (Ed). Respiratory infections: diagnosis and management (1983), Raven Press, New York 353-373
39. Fiese M.J. Coccidioidomycosis (1958), Charles C. Thomas, Springfield (IL)
40. Werner S.B., Pappagianis D., Heindl I., et al. An epidemic of coccidioidomycosis among archeology students in northern California. N Engl J Med 286 (1972) 507-512
41. Lonky S.A., Catanzaro A., Moser K., et al. Acute coccidioidal pleural effusion. Am Rev Respir Dis 114 (1976) 681-688
42. Blair J.E., and Douglas D.D. Coccidioidomycosis in liver transplant recipients relocating to an endemic area. Dig Dis Sci 49 (2004) 1981-1985
43. Wright P.W., Pappagianis D., Wilson M., et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 37 (2003) 1265-1269
44. Hart P.D., Russell Jr. E., and Remington J.S. The compromised host and infection. II. Deep fungal infection. J Infect Dis 120 (1969) 169-191
45. Blair J.E., and Logan J.L. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 33 (2001) 1536-1544
46. Cohen I.M., Galgiani J.N., Potter D., et al. Coccidioidomycosis in renal replacement therapy. Arch Intern Med 142 (1982) 489-494
47. Ampel N.M. Coccidioidomycosis among persons with human immunodeficiency virus infection in the era of highly active antiretroviral therapy (HAART). Semin Respir Infect 16 (2001) 257-262
48. Fish D.G., Ampel N.M., Galgiani J.N., et al. Coccidioidomycosis during human immunodeficiency virus infection. Medicine (Baltimore) 69 (1990) 394-398
49. Deresinski S.C., and Stevens D.A. Coccidioidomycosis in compromised hosts. Medicine (Baltimore) 54 (1974) 377-395
50. Holt C.D., Winston D.J., Kubak B.M., et al. Coccidioidomycosis in liver transplant patients. Clin Infect Dis 24 (1997) 216-221
51. Rosenstein N., Emery K., Werner S., et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis 32 (2001) 708-715
52. Woods C.W., McRill C., Plikaytis B.D., et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis 181 (2000) 1428-1434
53. Harris R.E. Coccidioidomycosis complicating pregnancy. Obstet Gynecol 28 (1966) 401-405
54. Wack E.E., Ampel N.M., Galgiani J.N., et al. Coccidioidomycosis during pregnancy. Chest 94 (1988) 376-379
55. Caldwell J.W., Arsura E.L., Kilgore W.B., et al. Coccidioidomycosis in pregnancy during an epidemic in California. Obstet Gynecol 95 (2000) 236-239
56. Louie L., Ng S., and Hajjeh R. Influence of host genetics on the severity of coccidioidomycosis. Emerg Infect Dis 5 (1999) 672-680
57. Pappagianis D., Lindsay S., Beall S., et al. Ethnic background and the clinical course of coccidioidomycosis. Am Rev Respir Dis 120 (1979) 959-961
58. Lopez A.M., Williams P.L., and Ampel N.M. Acute pulmonary coccidioidomycosis mimicking bacterial pneumonia and septic shock: a report of two cases. Am J Med 95 (1993) 236-239
59. Larsen R.A., Jacobson J.A., Morris A.H., et al. Acute respiratory failure caused by primary pulmonary coccidioidomycosis. Am Rev Respir Dis 131 (1985) 797-799
60. Crum N.F., Groff H.L., Parrish J.S., et al. A novel use for drotrecogin alfa (activated): successful treatment of septic shock associated with coccidioidomycosis. Clin Infect Dis 39 (2004) E122-E123
61. Drutz D.J., and Catanzaro A. Coccidioidomycosis: state of the art. Part I. Am Rev Respir Dis 117 (1978) 559-585
62. Graybill J.R., Galgiani J.N., Stevens D.A., et al., for the NIAID Mycoses Study Group. Progress in treatment of systemic mycoses: recent trials of the mycoses study group. In vitro and in vivo evaluation of antifungal agents (1986), Elsevier, Amsterdam
63. Catanzaro A., Galgiani J.N., Levine B.E., et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. Am J Med 98 (1995) 249-256
64. Oldfield E.C.I., Bone W.D., Martin C.R., et al. Prediction of relapse after treatment of coccidioidomycosis. Clin Infect Dis 25 (1997) 1205-1210
65. Grant A.R., and Melick D.W. The surgical treatment of cavitary pulmonary coccidioidomycosis. Arch Surg 94 (1967) 559-565
66. Bayer A.S. Fungal pneumonias: pulmonary coccidioidal syndromes (part 2). Chest 79 (1981) 686-691
67. Cotton B.H., and Paulsen G.A. Surgical considerations in pulmonary coccidioidomycosis. Am J Surg 90 (1955) 101-106
68. Thadepalli H., Salem F.A., Mandal A.K., et al. Pulmonary mycetoma due to Coccidioides immitis. Chest 71 (1977) 429-430
69. Amundson D.E. Perplexing pericarditis caused by coccidioidomycosis. South Med J 86 (1993) 694-696
70. Schwartz E.L., Waldmann E.B., Payne R.M., et al. Coccidioidal pericarditis. Chest 70 (1976) 670-672
71. Chowdhury J.K., and Habibzadeh M.A. Disseminated coccidioidomycosis with pericarditis. Chest 71 (1977) 533-535
72. Bayer A.S., Yoshikawa T.T., Galpin J.E., et al. Unusual syndromes of coccidioidomycosis: diagnostic and therapeutic considerations. Medicine (Baltimore) 55 (1976) 131-152
73. Dewsnup D.H., Galgiani J.N., Graybill J.R., et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?. Ann Intern Med 124 (1996) 305-310
74. Weisman I.M., Moreno A.J., Parker A.L., et al. Gastrointestinal dissemination of coccidioidomycosis. Am J Gastroenterol 81 (1986) 589-593
75. Dooley D.P., Reddy R.K., and Smith C.E. Coccidioidomycosis presenting as an omental mass. Clin Infect Dis 19 (1994) 802-803
76. Phillips P., and Ford B. Peritoneal coccidioidomycosis: case report and review. Clin Infect Dis 30 (2000) 971-976
77. Deresinski S.C. Coccidioidomycosis of bones and joints. In: Stevens D.A. (Ed). Coccidioidomycosis: a text (1980), Plenum, New York 195-211
78. Lewicky Y.M., Roberto R.F., and Curtin S.L. The unique complications of coccidioidomycosis of the spine. A detailed time line of disease progression and suppression. Spine 29 (2004) E435-E441
79. Kelly P.C. Coccidioidal meningitis. In: Stevens D.A. (Ed). Coccidioidomycosis: a text (1980), Plenum, New York 163-193
80. Tucker R.M., Galgiani J.N., Denning D.W., et al. Treatment of coccidioidal meningitis with fluconazole. Rev Infect Dis 12 Suppl 3 (1990) S380-S389
81. Proia L.A., and Tenorio A.R. Successful use of voriconazole for treatment of Coccidioides meningitis. Antimicrob Agents Chemother 48 (2004) 2341
82. Cortez S.A.E., Walsh T.J., and Bennett J.E. Successful treatment of coccidioidal meningitis with voriconazole. Clin Infect Dis 36 (2003) 1619-1622
83. Tucker R.M., Denning D.W., DuPont B., et al. Itraconazole therapy for chronic coccidioidal meningitis. Ann Intern Med 112 (1990) 108-112
84. Drutz D.J. Amphotericin B in the treatment of coccidioidomycosis. Drugs 26 (1983) 337-346
85. Vincent T., Galgiani J.N., Huppert M., et al. The natural history of coccidioidal meningitis: VA-Armed Forces cooperative studies, 1955-1958. Clin Infect Dis 16 (1993) 247-254
86. Kleinschmidt-DeMasters B.K., Mazowiecki M., Bonds L.A., et al. Coccidioidomycosis meningitis with massive dural and cerebral venous thrombosis and tissue arthroconidia. Arch Pathol Lab Med 124 (2000) 310-314
87. Williams P.L., Johnson R., Pappagianis D., et al. Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review. Clin Infect Dis 14 (1992) 673-682
88. Johnson RH, Brown JF Jr, Holeman CW, et al. Coccidioidal meningitis: a 25-year experience with 194 patients. In: Einstein HE, Catanzaro A, editors. Coccidioidomycosis: proceedings of the 4th International Conference. Washington (DC): National Foundation for Infectious Diseases; 1985. p. 411-21.
89. Alazracki N.P., Fierer J., Halpern S.E., et al. Use of a hyperbaric solution for administration of intrathecal amphotericin B. N Engl J Med 290 (1974) 641-646
90. Stevens D., and Shatsky S. Intrathecal amphotericin B in the management of coccidioidal meningitis. Semin Respir Infect 16 (2001) 263-269
91. Graybill J.R., and Ellenbogen C. Complications with the Ommaya reservoirs in patients with granulomatous meningitis. J Neurosurg 38 (1977) 477-480
92. Vanden Bossche H., Marichal P., Gorrens J., et al. Mode of action studies: Basis for the search of new antifungal drugs. Ann N Y Acad Sci 544 (1988) 191-207
93. Anstead G., Corcoran G., Lewis J., et al. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis 40 (2005) 1770-1776
94. Chin T.W.F., Loeb M., and Fong I.W. Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole. Antimicrob Agents Chemother 39 (1995) 1671-1678
95. Daneshmend T.K., Warnock D.W., and Ene M.D. Influence of food on the pharmacokinetics of ketoconazole. Antimicrob Agents Chemother 25 (1984) 1-3
96. Defelice R., Galgiani J.N., Campbell S.C., et al. Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study. Am J Med 72 (1982) 681-687
97. Catanzaro A., Einstein H., Levine B., et al. Ketoconazole for treatment of disseminated coccidioidomycosis. Ann Intern Med 96 (1982) 436-440
98. Graybill J.R., Craven P.C., Donovan W., et al. Ketoconazole therapy for systemic fungal infections: inadequacy of standard dosage regimens. Am Rev Respir Dis 126 (1982) 171-174
99. Ross J.B., Levine B., Catanzaro A., et al. Ketoconazole for treatment of chronic pulmonary coccidioidomycosis. Ann Intern Med 96 (1982) 440-443
100. Galgiani J.N., Stevens D.A., Graybill J.R., et al., for the NIAID Mycoses Study Group. Ketoconazole therapy of progressive coccidioidomycosis. Comparison of 400 and 800 mg doses and observations at higher doses. Am J Med 84 (1988) 603-610
101. Pont A., Williams P.L., Loose D.S., et al. Ketoconazole blocks adrenal steroid synthesis. Ann Intern Med 97 (1982) 370-372
102. Pont A., Williams P.L., Azhar S., et al. Ketoconazole blocks testosterone synthesis. Arch Intern Med 142 (1982) 2137-2140
103. Como J.A., and Dismukes W.E. Oral azole drugs as systemic antifungal therapy. N Engl J Med 330 (1994) 263-272
104. Barone J.A., Koh J.G., Bierman R.H., et al. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicrob Agents Chemother 37 (1993) 778-784
105. Barone J.A., Moskovitz B.L., Guarnieri J., et al. Enhanced bioavailability of itraconazole in hydroxyprolyl-beta-cyclodextrin solution versus capsules in healthy volunteers. Antimicrob Agents Chemother 42 (1998) 1862-1865
106. Sharkey P.K., Rinaldi M.G., Dunn J.F., et al. High dose itraconazole in the treatment of severe mycoses. Antimicrob Agents Chemother 35 (1991) 707-713
107. Catanzaro A, Cloud G, Stevens D, et al. Safety and tolerance of posaconazole (SCH56592) in patients with nonmeningeal coccidioidomycosis [abstract 1417]. Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy 2000;40.
108. Antony S. Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient. Clin Infect Dis 39 (2004) 879-880
109. Kuberski T.T., Servi R.J., and Rubin P.J. Successful treatment of a critically ill patient with disseminated coccidioidomycosis, using adjunctive interferon-gamma. Clin Infect Dis 38 (2004) 910-912
110. Bar-Oz B., Moretti M.E., Bishai R., et al. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. Am J Obstet Gynecol 183 (2000) 617-620
111. Galgiani J.N., Ampel N.M., Catanzaro A., et al. Practice guidelines for the treatment of coccidioidomycosis. Clin Infect Dis 30 (2000) 658-661
112. Hostetler J.S., Catanzaro A., Stevens D.A., et al. Treatment of coccidioidomycosis with SCH39304. J Med Vet Mycol 32 (1994) 105-114
113. Graybill J.R. Treatment of coccidioidomycosis. Ann N Y Acad Sci 544 (1988) 481-487